Mavyret Tablet, Film Coated
Product Images NDC 0074-2625

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mavyret (NDC 0074-2625). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glecaprevir (Mavyret Spl 01)

Chemical structure of Glecaprevir, one of the active ingredients in Mavyret (Glecaprevir and Pibrentasvir), depicted with stereochemistry and hydration (X H2O).*

FDA Label Image

Pibrentasvir (Mavyret Spl 02)

Chemical structure diagram of Glecaprevir, one of the active ingredients in Mavyret tablets. The diagram depicts the molecular structure including rings, fluorine atoms, methyl groups, and stereochemistry.*

FDA Label Image

Instructions For Use (Mavyret Spl 03)

Mavyret (Glecaprevir and Pibrentasvir) oral medication guide cover page. The label features cartoon figures holding stop signs and instructs patients to read the entire medication guide before use. It includes manufacturer details for AbbVie Inc. and a QR code. The design is mainly white with red and orange accents.*

FDA Label Image

Instructions For Use (Mavyret Spl 04)

An illustrated step-by-step guide showing how to prepare and administer Mavyret (Glecaprevir and Pibrentasvir) medication by mixing pellets with food. It includes instructions for finding the correct number of packets, choosing soft foods that stick to the spoon, preparing the dose, adding pellets, mixing well, and administering the medication with safety precautions and contact information for questions.*

FDA Label Image

Principal Display Panelndc 0074-2625-28rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgthis Carton Contains 21 Tablets Packaged As Follows:7 Wallets For 1 Week Of Treatment. Each Wallet Contains 3 Tablets.do Not Use If Seal On Top Of Carton Is Broken Or Missingkeep Out Of Reach Of Childrenstore At Or Below 30°c (86°f)see Package Insert For Full Prescribing Informationabbvie Inc.north Chicago, Il 60064©2020 Abbvie Inc.abbvie (Mavyret Spl 05)

Packaging label for Mavyret 100 mg/40 mg film-coated tablets containing Glecaprevir and Pibrentasvir. The label features the AbbVie Inc. logo and includes medication and usage instructions on a predominantly white and orange background, with areas for barcodes and product identification.*

FDA Label Image

Principal Display Panelndc 0074-2625-01rx Onlymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mgplease See Accompanying Full Prescribing Informationeach Box Contains: 1 Wallet Of 3 Tablets Eachkeep Out Of Reach Of Childrenstore At Or Below 30°c (86°f)see Package Insert For Full Prescribing Informationabbvie Inc.north Chicago, Il 60064product Of Ireland©2020 Abbvie Inc.abbvie (Mavyret Spl 06)

Mavyret 100 mg / 40 mg film-coated tablet carton packaging label by AbbVie Inc. The label shows the proprietary name Mavyret with the active ingredients Glecaprevir and Pibrentasvir listed at 100 mg and 40 mg per tablet. The packaging includes barcode and storage instructions, with a distinctive curved yellow and red design element on the front panel. The label also contains required regulatory information and markings.*

FDA Label Image

Principal Display Panelndc 0074-2625-28rx Only4-week Supplymavyret®(glecaprevir And Pibrentasvir)100mg / 40mgeach Tablet Contains Glecaprevir And Pibrentasvir 100mg / 40mg (Mavyret Spl 07)

Mavyret 100 mg/40 mg film-coated tablet packaging label for oral use. The label displays the proprietary name Mavyret with the generic names glecaprevir and pibrentasvir. It indicates a 4-week supply, with detailed labeling by AbbVie Inc. The design includes an orange and yellow curved graphic and shows barcodes and text for product identification.*

FDA Label Image

Principal Display Panelndc 0074-2625-80rx Onlymavyret®glecaprevir/pibrentasvir Tablets100 mg/40 mg For Institutional Use Only84 Tabletsabbviedo Not Accept If Seal Over Bottle Opening Is Broken Or Missing.each Tablet Contains Glecaprevir And Pibrentasvir 100 mg/40 mg.store At Or Below 30°c (86°f).see Package Insert For Full Prescribing Information.abbvie Inc.north Chicago, Il 60064 Usasee Opposite Side Of Label For Customs Country Of Origin.©2020 Abbvie Inc. (Mavyret Spl 08)

Label of Mavyret 100 mg/40 mg film-coated tablets containing glecaprevir and pibrentasvir. The label indicates prescription use, 84 tablets per package, for institutional use only, with storage instructions and manufacturer AbbVie Inc. information. It includes a barcode and batch details area.*

FDA Label Image

Principal Display Panelndc 0074-2625-28rx Onlymavyret®(glecaprevir/pibrentasivir) Oral Pellets50 mg/20 mgeach Packet Contains Pink And Yellow Oral Pellets.keep Out Of Reach Of Children.store At Or Below 30°c (86°f). Recommended Dosage: See Prescribing Information.abbvie Inc.north Chicago, Il 60044see Side Of Carton For Customs Country Of Origin.©2021 Abbvie Inc.abbvie (Mavyret Spl 09)

Packaging label for Mavyret 50 mg/20 mg film-coated tablets by AbbVie Inc. The label indicates the active ingredients as glecaprevir and pibrentasvir. The package contains oral packets with each packet having red and yellow oval patterns. Three individual packets are visible alongside the outer carton layout.*

FDA Label Image

Principal Display Panelndc 0074-2625-84rx Onlymavyret®glecaprevir/pibrentasvir Tablets100 mg/40 mg84 Tabletsdo Not Accept If Seal Over Bottle Opening Is Broken Or Missing.each Tablet Contains Glecaprevir And Pibrentasvir 100 mg / 40 mg.store At Or Below 30°c (86°f).see Package Insert For Full Dosing And Prescribing Information.see Bottom Of Carton For Customs Country Of Origin.abbvie Inc.north Chicago, Il 60064 Usa©2020 Abbvie Inc.abbvie (Mavyret Spl 0a)

Packaging label for Mavyret 100 mg/40 mg film-coated tablets, containing glecaprevir and pibrentasvir. The label indicates a supply of 84 tablets, manufactured by AbbVie Inc. It includes storage instructions to store at or below 30°C and warnings about seal integrity. The design features the Mavyret logo, strength in a yellow box, and various regulatory and product information including barcodes and a placeholder for a 2D barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.